KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (KMTS)

CUSIP: G52441105

Q4 2025 13F Holders as of 31 Dec 2025

Holder snapshot 6 signals
Share change
+5,188,231
SEC-reported price per share
$26.52
Indexed holders
108
Value change
+$139,802,244
Number of buys
82
Number of sells
17
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
58,457,647

Security key

G52441105

Report period

Q4 2025

Indexed institutions

108

Top holders

10

Ownership snapshot

Top reported holders of KMTS - KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Bain Charger Holdings, L.P.
Disclosed value leader
BAIN CAPITAL INVESTORS LLC
Comparable rows
3/15
Latest evidence
31 Dec 2025
13D/G 13F 3/4/5 Lead comparable stake: 43% 12 rows are not safely comparable across share classes. 13D/G row: Bain Charger Holdings, L.P. Showing 1-6 of 15 holder rows.

Quick read

Bain Charger Holdings, L.P. leads the comparable SEC ownership view at 43%.

3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Bain Charger Holdings, L.P.'s linked filing trail.
Comparable ownership Top 3
Bain Charger Holdings, L.P. 43%
FMR LLC 10%
Endeavour Medtech Growth II LP 4.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Bain Charger Holdings, L.P.
13D/G
43%
Reported 13D/G · 31 Dec 2025
$554,798,330
25,172,338 shares
-$40,705,389 31 Dec 2025
FMR LLC
13F 13D/G
Company
10%
Reported 13D/G · 30 Sep 2025
$125,404,995
5,277,988 shares
— 30 Sep 2025
Endeavour Medtech Growth II LP
13D/G
4.2%
Reported 13D/G · 31 Dec 2025
$53,974,682
2,448,942 shares
-$4,362,972 31 Dec 2025
BAIN CAPITAL INVESTORS LLC
13F 3/4/5
Company · 10%+ Owner
—
denominator unverified
$641,976,786
27,019,225 shares
— 30 Sep 2025
Christopher R. Gordon
3/4/5
Director, 10%+ Owner
—
denominator unverified
—
27,019,225 shares
— 06 Mar 2025
Fan Yu
13F
Individual
13F
—
denominator unverified
$54,232,651
2,282,519 shares
— 30 Sep 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
108
Shares
56,150,806
Indexed holders
108
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q4 2025 vs Q3 2025 Across Filers

Q3 2025 indexed holders
79
Q4 2025 indexed holders
108
Indexed holder difference
29
Investor Q3 2025 Shares Q4 2025 Shares Share Diff Share Chg % Q3 2025 value Q4 2025 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .